Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  razoxane
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 32 for your search:
Start Over
Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-784651
Phase II-III Study with 5-FU/ICRF-159/MeCCNU, 5-FU/ADR with or without MITO or MeCCNU, and 5-FU/MeCCNU for Unresectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376, MAYO-764101
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 14 to 75
Sponsor: NCI
Protocol IDs: EST-3377
Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-764802
Phase III 5-FU vs 5-FU/HU vs 5-FU/HU/MeCCNU/DTIC vs MeCCNU/DTIC vs MeCCNU/ICRF vs MITO/DTIC for Advanced Colon and Rectal Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1278
Phase I-II Combination Chemotherapy with MITO plus ICRF in Previously Treated Patients with Colorectal Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-048-090, WCCC-CO-7722
Phase I-II Chemotherapy with ICRF-159/Adriamycin for Advanced Metastatic Adenocarcinoma of the Gastrointestinal Tract
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-78GI0102, SEG-78GI238
Phase II Chemotherapy with ICRF-159 for Nonlymphomatous Sarcomas and Other Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WLT-26
Phase I Study of Combination Therapy with Adriamycin plus ICRF-159 for Nonlymphomatous Solid Malignant Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WLT-29
Phase I/II Optimal Dose Level Pilot Study of 5-FU, ICRF-159, MeCCNU plus Triazinate in Various Two-Drug Combinations for Large Bowel Carcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-770304
Phase II Chemotherapy with ICRF-159 and Cytosine Arabinoside for Acute Lymphocytic and Myelogenous Leukemias and Malignant Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-P-7806, NCI-D78-043-186
Phase II Chemotherapy with ICRF-159/MITO/5-FU and ICRF-159/MITO for Gastrointestinal, Breast, and Ovarian Adenocarcinomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-013-134
Phase II Trial of ICRF-159 in the Treatment of Advanced Gastric Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-77-C-67, NCI-VA-MOB-7617
Phase II Chemotherapy with ICRF-159 for Pediatric Solid Tumors and Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor: NCI
Protocol IDs: POG-7326, MDAR-49
Phase II Trial of ICRF-159 for Refractory Lymphomas
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: WCG-144
Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-805002, NCCTG-805002, NCI-W81-0587
Phase II Master Protocol Chemotherapy in Patients with AIDS and Kaposi's Sarcoma --- ICRF-159, with VBL for Failures
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: NCOG-0C822A
Phase II Master Protocol for Advanced, Recurrent Pelvic Malignancies: ICRF-159
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26G
Phase II Master Protocol for Chemotherapy for Refractory Mycosis Fungoides/Sezary Syndrome --- HMM, ICRF-159, DBD
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-061-831
Phase II Pilot Chemotherapy with ICRF-159/CACP for Advanced Carcinoma of the Cervix
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-8191
Phase II Evaluation of ICRF-159 Chemotherapy for Refractory Lymphoma and Mycosis Fungoides
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1477
Phase II Chemotherapy with ADR/VCR, ADR/VCR/DBD, ADR/VCR/ICRF-159, or DBD Alone for Disseminated Breast Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: under 70
Sponsor: NCI
Protocol IDs: EST-2175, UICC-76064
Phase II Chemotherapy with MTX, ICRF-159, Triazinate, and High-Dose MTX/CF Rescue for Advanced Gastric Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8477
A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- HMM, DAG, b-TGdR, ICRF-159
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9376A
Phase II Chemotherapy with Chromomycin, Cytembena, ICRF-159 or 5-FU/MeCCNU, 5-FU/MeCCNU/VCR, or 5-FU/CACP for Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-701831
Start Over